Clinical Trial Update: Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Treo/Flu/TBI with donor stem cell transplant for myelodysplastic syndrome or acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• Treo/Flu/TBI with donor stem cell transplant

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Myeloid Leukemia in Remission, Chronic Myelomonocytic Leukemia | Phase 2 | Status: UNKNOWN | Results posted: 2018-05-21